Clinical Trials Logo

Cerebrovascular Stroke clinical trials

View clinical trials related to Cerebrovascular Stroke.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05028855 Recruiting - Clinical trials for Cerebrovascular Stroke

Cerebral Autoregulation in Patients With Symptomatic Cerebral Atherosclerotic Stenosis

CASCAS
Start date: January 14, 2017
Phase:
Study type: Observational [Patient Registry]

In this multi-center prospective observational study within a cohort of symptomatic cerebral atherosclerotic stenosis (sCAS) patients, 850 subjects were planed to be enrolled to explore the relationship between cerebral autoregulation (CA) and stroke recurrence, determine the threshold values of CA parameter for predicting stroke recurrence associated with particular stenosis.

NCT ID: NCT04934787 Recruiting - Clinical trials for Cerebrovascular Stroke

ENMS With Balance Feedback for Post-stroke Ankle-foot Rehabilitation

Start date: July 1, 2021
Phase: N/A
Study type: Interventional

In this work, a novel hybrid ankle-foot robot is designed for gait rehabilitation after stroke, i.e., exoneuromusculoskeleton with balance sensing feedback (ENMS-BSF) by integrating the advantages of soft pneumatic muscle, functional electrical stimulation, exoskeleton and foot balance feedback in one system. With the assistance of the ENMS-BSF the foot drop and foot inversion could be corrected with improved muscle coordination in the paretic lower limb. The device is wearable and light-in-weight for unilateral application during walking. It is hypothesized that with the intervention of the ENMS-BSF the gait pattern of persons after stroke can be improved with long-term rehabilitative effects.

NCT ID: NCT04297345 Recruiting - Clinical trials for Cerebrovascular Stroke

Feasibility and Safety Study to Evaluate the Neuroprotective Effect of Hemodialysis in Acute Ischemic Stroke

DIAGLUICTUS2
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

Hemodialysis is a therapeutic strategy used in subjects with chronic renal failure. Our working hypothesis is based on results published in experimental animal models of stroke where the investigators have demonstrated that peritoneal dialysis is an effective technique to reduce blood glutamate levels and reduce infarct volume. The objective of this clinical trial is to evaluate the viability, safety and efficacy of hemodialysis in patients with acute ischemic stroke, proposing that it may have a) a potential neuroprotective effect by reducing the excitotoxic levels of glutamate and proinflammatory cytokines in blood and b) fewer technical problems than peritoneal dialysis to apply in usual clinical practice.

NCT ID: NCT03772457 Recruiting - Clinical trials for Intracranial Hemorrhages

Predictive Value of Infarction Volume on Hemorrhagic Transformation in Ischemic Stroke/TIA With Non-valve Atrial Fibrillation(NVAF) Patients Using Rivaroxaban

Start date: January 18, 2019
Phase:
Study type: Observational

This study was aimed at patients with newly diagnosed stroke / TIA associated with nonvalvular atrial fibrillation. We will observe the effect of early using rivaroxaban anticoagulation on hemorrhagic transformation, and explore the predictive value of multi-mode MRI infarct volume / MMP-9 on hemorrhagic transformation after anticoagulation therapy.

NCT ID: NCT02587949 Recruiting - Clinical trials for Cerebrovascular Stroke

The Correlation Between Hair Cortisol Level of Acute Stroke or Its Long Term Disability.

Start date: November 2015
Phase:
Study type: Observational

In patients admitted to hospital with acute cerebrovascular stroke, we want to study the relationship between hair cortisol levels and biomarkers of inflammation and the clinical and radiological severity of the stroke and the degree of neurological disability being tested in three months and one year after.

NCT ID: NCT01144650 Recruiting - Stroke Clinical Trials

Dapsone for Acute Ischemia Stroke Study

DAISY
Start date: July 2009
Phase: Phase 2/Phase 3
Study type: Interventional

The main purpose of the study is to get information about the safety and efficacy of treatment with Dapsone to prevent the disability after ischemic Stroke, in patients diagnosed with anterior territory brain infarct.